Quadrant Capital Group’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,280
| Closed | -$11.7K | – | 2735 |
|
|
2024
Q3 | $11.7K | Buy |
12,280
+9,062
| +282% | +$8.61K | ﹤0.01% | 2097 |
|
|
2024
Q2 | $3.14K | Sell |
3,218
-3,035
| -49% | -$2.96K | ﹤0.01% | 2403 |
|
|
2024
Q1 | $9.88K | Buy |
+6,253
| New | +$9.88K | ﹤0.01% | 2110 |
|
|
2022
Q4 | – | Sell |
-1,046
| Closed | -$1K | – | 2734 |
|
|
2022
Q3 | $1K | Buy |
+1,046
| New | +$1K | ﹤0.01% | 2457 |
|
|
2022
Q1 | – | Sell |
-2,466
| Closed | -$9K | – | 2473 |
|
|
2021
Q4 | $9K | Sell |
2,466
-754
| -23% | -$2.75K | ﹤0.01% | 1654 |
|
|
2021
Q3 | $17K | Buy |
+3,220
| New | +$17K | ﹤0.01% | 1315 |
|
|
2020
Q3 | – | Sell |
-131
| Closed | -$1K | – | 2149 |
|
|
2020
Q2 | $1K | Buy |
+131
| New | +$1K | ﹤0.01% | 2000 |
|